This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
“I don’t think an algorithm can re-create the specifically human experiences” of...
The NIH canceled Logan Beyer’s health equity research, saying it was “antithetic...
Academic groups announced an effort to develop a “simple and easily explained mo...
Researchers at Harvard and its affiliates appreciate that the university resiste...
Audience: Consumers April 14, 2025 -- FDA was notified by Novo Nordisk on April ...
PLAINSBORO, N.J., April 14, 2025 /PRNewswire/ -- Novo Nordisk has become aware o...
INCHEON, South Korea, April 14, 2025 /-- Celltrion, Inc. today announced that th...
BRIDGEWATER, New Jersey and BENGALURU, Karnataka, India, April 10, 2025 -- Bioco...
FOSTER CITY, Calif.--(BUSINESS WIRE) April 14, 2025 -- Mirum Pharmaceuticals, I...
State AGs are concerned about conflicts of interest that allow PBMs to dominate ...
The Commerce Department has begun a so-called Section 232 investigation into the...
BOSTON--(BUSINESS WIRE) April 14, 2025 -- Ironwood Pharmaceuticals, Inc. (Nasda...
The Trump administration disclosed that it had formally opened an investigation ...
MONDAY, April 14, 2025 -- Recent major events, including hurricanes Irma and Ma...
PRINCETON, N.J.--(BUSINESS WIRE) April 11, 2025 -- Bristol Myers Squibb (NYSE: ...
Amid an FDA overhaul and market volatility, one biotech executive says her publi...
NEW YORK--(BUSINESS WIRE) April 14, 2025 -- Pfizer Inc. (NYSE: PFE) today announ...
Amgen CEO Robert Bradway scored $24.4 million in total compensation last year, h...
The market turbulence unleashed by President Donald Trump’s tariff policies will...
Aurobindo's Aurolife Pharma has received a Form 483 from the FDA outlining 11 ob...
The U.K. is rolling out new regulations meant to reduce red tape for clinical st...
The U.K. is rolling out new regulations meant to reduce red tape for clinical st...